Treatment of delusions in dementia with Lewy bodies - Response to pharmacotherapy

Dementia and Geriatric Cognitive Disorders

Volumn 23, Issue 5, 2007, Pages 307-311

  Fischer, Corinne ^a,b   Bozanovic, Radenka ^c   Atkins, Jana H ^a   Rourke, Sean B ^a,b,d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d ONTARIO HIV TREATMENT NETWORK   (Canada)

Author keywords

Antipsychotics; Delusions; Dementia with Lewy bodies; Neuroleptics; Psychosis

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RIVASTIGMINE;

ANTICHOLINERGIC EFFECT; CLINICAL TRIAL; DELUSION; DEMENTIA; DISEASE EXACERBATION; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HUMAN; LEWY BODY; MEDLINE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOMNOLENCE; UNSPECIFIED SIDE EFFECT;

ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; DELUSIONS; HALLUCINATIONS; HUMANS; LEWY BODY DISEASE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34247359494     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100901     Document Type: Review

References (19)

1. McKeith IG, Mintzer J, Aarsland D, et al: Dementia with Lewy bodies. Lancet Neurol 2004;3:19-28.
2. Litvan I, Bhatia KP, Burns DJ, et al: SIC Task Force Appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003;18:467-486.
3. McKeith IG, Dickson DW, Lowe J, et al: Diagnosis and management of dementia with Lewy bodies. Neurology 2005;65:1863-1872.
4. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK: Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
5. Birkett DP, Deseousky A, Han L, Kaufman M: Lewy bodies in psychiatric patients. Int J Geriatr Psychiatry 1992;7:235-240.
6. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E: Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-678.
7. Swanberg MM, Cummings JL: Benefit-risk considerations in the treatment of dementia with Lewy bodies. Drug Saf 2002;25:511-523.
8. Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG: Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry 2005;66:633-637.
9. Ballard C, Piggot M, Johnson M, Cairns N, Perry R, McKeith I, Jaros E, O'Brien J, Holmes C, Perry E: Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol 2000;48:868-876.
10. Edwards KR, Hershey L, Wray L, Bednarczyk EM, Lichter D, Farlow M, Johnson S: Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis. Dement Geriatr Cogn Disord 2004;17:40-48.
11. Lanctot K, Herrmann N: Donepezil for behavioural disorders associated with Lewy bodies: a case series. Int J Geriatr Psychiatry 2000;15:338-345.
12. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Cicin-Sain A, Ferrara R, Spiegel R: Efficacy of rivastigmine in dementia with Lewy bodies: a randomized, double-blind, placebo-controlled international study. Lancet 2000;356:2031-2036.
13. McKeith I, Grace J, Walker Z, Byrne EJ, Wilkinson D, Stevens T, Perry EK: Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. Int J Geriatr Psychiatry 2000;15:387-392.
14. Cummings JL, Street J, Masterman D, Clark SW: Efficacy of olanzapine in the treatment of psychosis in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2002;13:67-73.
15. Takahashi H, Yoshido K, Sugita T, Higuchi H, Shimizu T: Quetiapine treatment of psychotic symptoms and aggressive behaviour in patients with dementia with Lewy bodies: a case series. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:549-553.
16. Goldsmith SK, Shapiro RM, Joyce JN: Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia: a postmortem study. Arch Gen Psychiatry 1997;54:649-658.
17. Paulsen JS, Ready RE, Stout JC, Salmon DP, Thal LJ, Grant I, Jeste DV: Neurobehaviors and psychotic symptoms in Alzheimer's disease. J Int Neuropsychol Soc 2000;6:815-820.
18. Ballard C, Jacoby R, Del Ser T, et al: Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with Lewy bodies. Am J Psychiatry 2004;161:843-849.
19. Teaktong T, Piggott MA, McKeith IG, Perry RH, Ballard CG, Perry EK: Muscarnic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies. Behav Brain Res 2005;161:299-305.